TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Biovest International, Inc. (Other OTC: BVTI) today congratulated Dr. Larry Kwak for being named in the “2010 TIME 100” issue of TIME Magazine, recognizing his significant contributions in advancing personalized cancer vaccines for the treatment of cancer. Dr. Kwak serves as Chairman, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and as a consultant to Biovest was the lead investigator for the Phase II and Phase III clinical trials for BiovaxID®, Biovest’s active immunotherapy targeting the treatment of certain B-cell lymphomas.
